LumiraDx (LumiraDx) Market Cap : $5.4 Mil (As of Apr. 28, 2024)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LumiraDx's share price for the quarter that ended in Jun. 2023 was $0.48. LumiraDx's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 319.1 Mil. Therefore, LumiraDx's market cap for the quarter that ended in Jun. 2023 was $153.2 Mil.

LumiraDx's quarterly market cap declined from Dec. 2022 ($286.7 Mil) to Mar. 2023 ($148.1 Mil) but then increased from Mar. 2023 ($148.1 Mil) to Jun. 2023 ($153.2 Mil).

LumiraDx's annual market cap increased from Dec. 2020 ($0.0 Mil) to Dec. 2021 ($2,251.6 Mil) but then declined from Dec. 2021 ($2,251.6 Mil) to Dec. 2022 ($286.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LumiraDx's Enterprise Value for Today is $382.3 Mil.

LumiraDx Market Cap Historical Data

The historical data trend for LumiraDx's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Market Cap Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Market Cap

2,251.59

286.69

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Market Cap	Get a 7-Day Free Trial								678.88	324.04	286.69	148.12	153.18

Competitive Comparison of LumiraDx's Market Cap

For the Diagnostics & Research subindustry, LumiraDx's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LumiraDx's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LumiraDx's Market Cap distribution charts can be found below:

* The bar in red indicates where LumiraDx's Market Cap falls into.

LumiraDx Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

LumiraDx's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$0.9	*	318.546
	=	$286.7

LumiraDx's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	$0.48	*	319.129
	=	$153.2

LumiraDx (OTCPK:LMDXF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

LumiraDx Market Cap Related Terms

Thank you for viewing the detailed overview of LumiraDx's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.